MAPK pathway activation in pilocytic astrocytoma.
David T W Jones1, Jan Gronych, Peter Lichter
1Division of Molecular Genetics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Cellular and Molecular Life Sciences : CMLS
|December 14, 2011
Summary
Pilocytic astrocytoma (PA) involves the mitogen-activated protein kinase (MAPK) pathway. BRAF gene fusions are common in PA, offering potential for targeted therapies.
Area of Science:
- Neuro-oncology
- Molecular biology
- Pediatric oncology
Background:
- Pilocytic astrocytoma (PA) is the most prevalent pediatric central nervous system (CNS) tumor.
- Mitogen-activated protein kinase (MAPK) pathway signaling is crucial in PA development and progression.
- Mutually exclusive mechanisms activate the MAPK pathway in PA, with BRAF gene fusions being most frequent.
Purpose of the Study:
- To review current knowledge on MAPK pathway activation mechanisms in pilocytic astrocytoma.
- To discuss the downstream consequences of MAPK activation in PA.
- To explore clinical implications and future therapeutic directions for PA.
Main Methods:
- Literature review of existing research on MAPK pathway in pilocytic astrocytoma.
- Analysis of genetic alterations, particularly BRAF fusions, in PA.
- Examination of in vitro and in vivo studies on MAPK pathway consequences.
Main Results:
- Constitutive BRAF kinase activation via gene fusion is the most common MAPK pathway alteration in PA.
- MAPK pathway alterations are highly specific to PA, aiding in diagnosis.
- Downstream effects of MAPK activation are increasingly understood through experimental models.
Conclusions:
- The MAPK pathway, especially BRAF fusions, is a key driver in pilocytic astrocytoma.
- The specificity of BRAF fusions offers diagnostic value for PA.
- Targeted therapies focusing on the MAPK pathway represent a promising future direction for PA treatment.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...